2004
DOI: 10.1111/j.1365-2222.2004.02006.x
|View full text |Cite
|
Sign up to set email alerts
|

Trichostatin A attenuates airway inflammation in mouse asthma model

Abstract: TSA attenuated the development of allergic airway inflammation by decreasing expression of the Th2 cytokines, IL-4 and IL-5, and IgE, which resulted from reduced T cell infiltration. Our results suggest that HDAC inhibition may attenuate the development of asthma by a T cell suppressive effect.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

11
133
2

Year Published

2005
2005
2018
2018

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 172 publications
(146 citation statements)
references
References 40 publications
11
133
2
Order By: Relevance
“…In contrast, comprehensive evidence from experiments with isolated lungs and those with intact animals suggest that on the protein level the overall effect of TSA in vivo tends to be anti-inflammatory. This conclusion is corroborated by the antiinflammatory action of HDACi in experimental models of acute lung injury (this study), asthma [20], sepsis [21], arthritis [22,38], autoimmune encephalomyelitis [39], colitis [40] and concanavalin-A-induced hepatitis [21]. From the present study we suggest that the discrepancies between the in vivo and perfused lung studies on the one hand, and the cell culture studies on the other may be ascribed to the focus on M A N U S C R I P T has not revealed a pattern that correlated with the current findings (data not shown).…”
Section: Discussionsupporting
confidence: 78%
See 2 more Smart Citations
“…In contrast, comprehensive evidence from experiments with isolated lungs and those with intact animals suggest that on the protein level the overall effect of TSA in vivo tends to be anti-inflammatory. This conclusion is corroborated by the antiinflammatory action of HDACi in experimental models of acute lung injury (this study), asthma [20], sepsis [21], arthritis [22,38], autoimmune encephalomyelitis [39], colitis [40] and concanavalin-A-induced hepatitis [21]. From the present study we suggest that the discrepancies between the in vivo and perfused lung studies on the one hand, and the cell culture studies on the other may be ascribed to the focus on M A N U S C R I P T has not revealed a pattern that correlated with the current findings (data not shown).…”
Section: Discussionsupporting
confidence: 78%
“…HDACi have been suggested as drugs for the treatment of several inflammatory disorders including asthma, COPD, lupus erythematosus or arthritis [3,4,20,44,45], as well as cancer [2]. Given the contradictory effects of TSA and other HDACi on the expression of many genes, their use as potential drugs is expected to have difficultto-predict effects and side effects.…”
Section: A C C E P T E D Article In Pressmentioning
confidence: 99%
See 1 more Smart Citation
“…We found that Յ1 M TSA has no significant effect on the viability of HUVEC as detected by trypan blue staining after a 24-h treatment (data not shown). For our studies, we chose doses and treatment times similar to those previously used successfully to investigate the influence of TSA on endothelial NO synthase expression and angiogenesis in HUVEC in vitro (15,32) and some inflammatory disease models in vivo (18,32).…”
Section: Tsa Inhibits Agonist-induced Tf Activity and Protein Expressmentioning
confidence: 99%
“…These results were complemented in vivo by investigating inflammatory models such as concanavalin A-induced hepatitis or LPS-induced shock in mice (7). Following these initial data, the anti-inflammatory potency could be confirmed in models of nephritis (8), arthritis (9), intestinal inflammation (6,10), graft versus host disease (11), and asthma (12). In addition, the HDAC inhibitor ITF2357 has shown clinical efficacy in clinical trials for juvenile arthritis (13).…”
mentioning
confidence: 95%